MetaADEDB 2.0 @ LMMD
azelastine
(YEJAJYAHJQIWNU-UHFFFAOYSA-N)
Structure
SMILES
CN1CCCC(CC1)n1nc(Cc2ccc(cc2)Cl)c2c(c1=O)cccc2.Cl
Molecular Formula:
C22H25Cl2N3O
Molecular Weight:
418.359
Log P:
5.0374
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
38.13
CAS Number(s):
37932-96-0; 79307-93-0
Synonym(s)
1.
azelastine
2.
4-((4-chlorophenyl)methyl)-2- (hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)- phthalazinone HCl
3.
4-(p-chlorobenzyl)-2-(N-methylperhydroazepinyl-(4))-1-(2H)-phthalazinone
4.
A 5610
5.
A-5610
6.
Afluon
7.
Allergodil
8.
Astelin
9.
Azeptin
10.
Corifina
11.
Loxin
12.
Optilast
13.
Optivar
14.
Rhinolast
15.
Vividrin akut Azelastin
16.
azelastine hydrochloride
External Link(s)
MeSHC020976
PubChem Compound50986914
54360
ChEBI2951
CHEMBLCHEMBL1200809
KEGGdr:D00659
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 247US FAERS
2DysgeusiaFAERS: 104US FAERS
3Nasal discomfortFAERS: 41US FAERS
4Wrong technique in product usage processFAERS: 36US FAERS
5DizzinessFAERS: 28US FAERS
6HeadacheFAERS: 28US FAERS
7SomnolenceFAERS: 28US FAERS
8SneezingFAERS: 25US FAERS
9Eye irritationFAERS: 21US FAERS
10NauseaFAERS: 20US FAERS
11Product quality issueFAERS: 17US FAERS
12EpistaxisFAERS: 16US FAERS
13Accidental exposure to productFAERS: 14US FAERS
14Throat irritationFAERS: 13US FAERS
15AnosmiaFAERS: 12US FAERS
16Oropharyngeal painFAERS: 12US FAERS
17FatigueFAERS: 11US FAERS
18HypersensitivityFAERS: 11US FAERS
19Product taste abnormalFAERS: 11US FAERS
20VomitingFAERS: 10US FAERS
21PalpitationsFAERS: 9US FAERS
22Product substitution issueFAERS: 9US FAERS
23PruritusFAERS: 9US FAERS
24RhinalgiaFAERS: 9US FAERS
25Feeling abnormalFAERS: 8US FAERS
26Incorrect dose administeredFAERS: 8US FAERS
27MalaiseFAERS: 8US FAERS
28AgeusiaFAERS: 7US FAERS
29Expired product administeredFAERS: 7US FAERS
30Eye painFAERS: 7US FAERS
31PainFAERS: 7US FAERS
32WheezingFAERS: 7US FAERS
33AnxietyFAERS: 6US FAERS
34SinusitisFAERS: 6US FAERS
35Chest discomfortFAERS: 5US FAERS
36Ear discomfortFAERS: 5US FAERS
37ErythemaFAERS: 5US FAERS
38No adverse eventFAERS: 5US FAERS
39Product use issueFAERS: 5US FAERS
40RetchingFAERS: 5US FAERS
41Chest PainFAERS: 4US FAERS
42DisorientationFAERS: 4US FAERS
43Drug ineffective for unapproved indicationFAERS: 4US FAERS
44FlushingFAERS: 4US FAERS
45Abdominal PainFAERS: 3US FAERS
46AstheniaFAERS: 3US FAERS
47Burning sensationFAERS: 3US FAERS
48DysphoniaFAERS: 3US FAERS
49Head discomfortFAERS: 3US FAERS
50MydriasisFAERS: 3US FAERS
51Neck PainFAERS: 3US FAERS
52Paranasal sinus hypersecretionFAERS: 3US FAERS
53Peripheral swellingFAERS: 3US FAERS
54Pharmaceutical product complaintFAERS: 3US FAERS
55SyncopeFAERS: 3US FAERS
56TachycardiaFAERS: 3US FAERS
57Upper-airway cough syndromeFAERS: 3US FAERS
58UrticariaFAERS: 3US FAERS
59Visual ImpairmentFAERS: 3US FAERS
60Abdominal discomfortFAERS: 2US FAERS
61Abdominal symptomFAERS: 2US FAERS
62AgitationFAERS: 2US FAERS
63ArthralgiaFAERS: 2US FAERS
64AsthmaFAERS: 2US FAERS
65AtaxiaFAERS: 2US FAERS
66Atrial FibrillationFAERS: 2US FAERS
67Choking sensationFAERS: 2US FAERS
68Contraindicated product administeredFAERS: 2US FAERS
69DiscomfortFAERS: 2US FAERS
70Drug administration errorFAERS: 2US FAERS
71Drug effect incompleteFAERS: 2US FAERS
72Ear congestionFAERS: 2US FAERS
73Eye InfectionFAERS: 2US FAERS
74Facial PainFAERS: 2US FAERS
75HypersomniaFAERS: 2US FAERS
76Inappropriate schedule of drug administrationFAERS: 2US FAERS
77Joint swellingFAERS: 2US FAERS
78LacerationFAERS: 2US FAERS
79LaryngitisFAERS: 2US FAERS
80LethargyFAERS: 2US FAERS
81Lip swellingFAERS: 2US FAERS
82Medication ErrorFAERS: 2US FAERS
83Memory impairmentFAERS: 2US FAERS
84Musculoskeletal PainFAERS: 2US FAERS
85MyalgiaFAERS: 2US FAERS
86NervousnessFAERS: 2US FAERS
87Product contaminationFAERS: 2US FAERS
88Product label issueFAERS: 2US FAERS
89SwellingFAERS: 2US FAERS
90TinnitusFAERS: 2US FAERS
91VertigoFAERS: 2US FAERS
92Visual disturbanceFAERS: 2US FAERS
93AbasiaFAERS: 1US FAERS
94Accidental drug intake by childFAERS: 1US FAERS
95Accidental overdoseFAERS: 1US FAERS
96Allergic sinusitisFAERS: 1US FAERS
97AlopeciaFAERS: 1US FAERS
98Altered visual depth perceptionFAERS: 1US FAERS
99AngerFAERS: 1US FAERS
100Animal biteFAERS: 1US FAERS
101Anticholinergic SyndromeFAERS: 1US FAERS
102Application site painFAERS: 1US FAERS
103Application site pruritusFAERS: 1US FAERS
104Application site scabFAERS: 1US FAERS
105BedriddenFAERS: 1US FAERS
106BlepharospasmFAERS: 1US FAERS
107BlindnessFAERS: 1US FAERS
108Blood glucose increasedFAERS: 1US FAERS
109BronchitisFAERS: 1US FAERS
110BronchospasmFAERS: 1US FAERS
111Cardiac ArrestFAERS: 1US FAERS
112Cerebrovascular accidentFAERS: 1US FAERS
113Chemical injuryFAERS: 1US FAERS
114ChokingFAERS: 1US FAERS
115Complication associated with deviceFAERS: 1US FAERS
116ConstipationFAERS: 1US FAERS
117CryingFAERS: 1US FAERS
118Deafness NeurosensoryFAERS: 1US FAERS
119DehydrationFAERS: 1US FAERS
120DeliriumFAERS: 1US FAERS
121Depressed Level of ConsciousnessFAERS: 1US FAERS
122DermatitisFAERS: 1US FAERS
123Disease recurrenceFAERS: 1US FAERS
124Documented hypersensitivity to administered drugFAERS: 1US FAERS
125Drug abuserFAERS: 1US FAERS
126Drug dispensing errorFAERS: 1US FAERS
127Drug dose omissionFAERS: 1US FAERS
128Dry skinFAERS: 1US FAERS
129Emotional disorderFAERS: 1US FAERS
130Expired drug administeredFAERS: 1US FAERS
131Eye allergyFAERS: 1US FAERS
132Eye inflammationFAERS: 1US FAERS
133Feeling jitteryFAERS: 1US FAERS
134FlatulenceFAERS: 1US FAERS
135GastroenteritisFAERS: 1US FAERS
136Gastrointestinal PainFAERS: 1US FAERS
137HungerFAERS: 1US FAERS
138Hypoaesthesia facialFAERS: 1US FAERS
139HypogeusiaFAERS: 1US FAERS
140HypothyroidismFAERS: 1US FAERS
141Impaired driving abilityFAERS: 1US FAERS
142Incorrect route of drug administrationFAERS: 1US FAERS
143InflammationFAERS: 1US FAERS
144InfluenzaFAERS: 1US FAERS
145Instillation site infectionFAERS: 1US FAERS
146Intentional product misuseFAERS: 1US FAERS
147Intentional product use issueFAERS: 1US FAERS
148Intercepted drug administration errorFAERS: 1US FAERS
149LeukoplakiaFAERS: 1US FAERS
150Lichen PlanusFAERS: 1US FAERS
151Medication tamperingFAERS: 1US FAERS
152Mental impairmentFAERS: 1US FAERS
153Middle insomniaFAERS: 1US FAERS
154MoaningFAERS: 1US FAERS
155Musculoskeletal stiffnessFAERS: 1US FAERS
156Nasal pruritusFAERS: 1US FAERS
157NystagmusFAERS: 1US FAERS
158Oral painFAERS: 1US FAERS
159Oropharyngeal blisteringFAERS: 1US FAERS
160Oropharyngeal swellingFAERS: 1US FAERS
161Panic DisorderFAERS: 1US FAERS
162Perioral DermatitisFAERS: 1US FAERS
163Periorbital contusionFAERS: 1US FAERS
164PneumoniaFAERS: 1US FAERS
165Poor quality drug administeredFAERS: 1US FAERS
166Prescription drug used without a prescriptionFAERS: 1US FAERS
167PresyncopeFAERS: 1US FAERS
168Product package associated injuryFAERS: 1US FAERS
169Product packaging issueFAERS: 1US FAERS
170Product physical consistency issueFAERS: 1US FAERS
171Product physical issueFAERS: 1US FAERS
172Productive CoughFAERS: 1US FAERS
173Reaction to preservativesFAERS: 1US FAERS
174Renal painFAERS: 1US FAERS
175Respiratory arrestFAERS: 1US FAERS
176Rheumatoid ArthritisFAERS: 1US FAERS
177ScabFAERS: 1US FAERS
178Sinus headacheFAERS: 1US FAERS
179Skin UlcerFAERS: 1US FAERS
180Skin irritationFAERS: 1US FAERS
181SnoringFAERS: 1US FAERS
182StomatitisFAERS: 1US FAERS
183Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
184Therapeutic response unexpectedFAERS: 1US FAERS
185Tongue blisteringFAERS: 1US FAERS
186Unevaluable eventFAERS: 1US FAERS
187Upper airway obstructionFAERS: 1US FAERS
188Urinary RetentionFAERS: 1US FAERS
189Urinary tract infectionFAERS: 1US FAERS
190Uterine spasmFAERS: 1US FAERS
191Vitamin D DeficiencyFAERS: 1US FAERS
192Vulvovaginal burning sensationFAERS: 1US FAERS
193Walking aid userFAERS: 1US FAERS
194Weight decreasedFAERS: 1US FAERS
195Wrong drug administeredFAERS: 1US FAERS
196treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.